Old Web
English
Sign In
Acemap
>
authorDetail
>
Tomomitsu Satoh
Tomomitsu Satoh
Yamaguchi University
Medicine
Pathology
Poly ICLC
Cancer research
LAG3
3
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I study of multi-HLA-binding HSP70 + GPC3 peptides and combination adjuvants of LAG3-Ig + Poly-ICLC against gastrointestinal cancers.
2018
Journal of Clinical Oncology
Shoichi Hazama
Koji Tamada
Keiko Udaka
Yasunari Koki
Toshinari Uematsu
Hideki Arima
Tomomitsu Satoh
Shun Doi
Tomoya Miyakawa
Hiroto Matsui
Shinsuke Kanekiyo
Yukio Tokumitsu
Kazuhiko Sakamoto
Nobuaki Suzuki
Shigeru Takeda
Shigeru Yamamoto
Shigefumi Yoshino
Tomio Ueno
Hiroaki Nagano
Show All
Source
Cite
Save
Citations (0)
A combination chemotherapy of weekly paclitaxel and doxifluridine (5'-DFUR: an intermediate metabolite of capecitabine) in patients with unresectable or recurrent gastric cancer in an outpatient setting. Final results of a multicenter phase II trial
2007
Journal of Clinical Oncology
Shigefumi Yoshino
Taku Nishimura
Shoichi Hazama
Masaaki Oka
H Ozasa
Ryoichi Shimizu
Takumi Furuya
Shintaro Fukuda
Tomomitsu Satoh
T. Hara
Show All
Source
Cite
Save
Citations (0)
Prediction of Nodal Metastasis by Comparative Genomic Hybridization in Biopsy Specimens from Patients with Superficial Esophageal Squamous Cell Carcinoma
2003
Clinical Cancer Research
Takashi Ueno
Akira Tangoku
Shigefumi Yoshino
Toshihiro Abe
Hideto Hayashi
Hiroaki Toshimitsu
Kiichiro Hashimoto
Tomomitsu Satoh
Atsunori Oga
Tomoko Furuya
Masaaki Oka
Kohsuke Sasaki
Show All
Source
Cite
Save
Citations (9)
1